SACRAMENTO, Calif., March 20, 2013 (GLOBE NEWSWIRE) -- NVN Therapeutics (www.nvnth.com) today announced its sponsorship of the non-profit support organization, PCOS Challenge, Inc., to help address one of the most common and critical issues impacting women's health today, polycystic ovarian syndrome (PCOS).
"As the developer of Glucorein™ PCOS for women, we understand how important reliable support resources are to individuals and families when dealing with any health or medical condition," said Susan Derence, director of sales for NVN Therapeutics. "We're extremely proud to sponsor the education and awareness efforts of PCOS Challenge. They are one of the leading support organizations for women with PCOS and are having a significant impact on the lives of thousands of women."
NVN Therapeutic's patent-pending Glucorein™ for Polycystic Ovarian Syndrome (PCOS) is patent-pending proprietary blend of chlorogenic acid and L-cysteine, which collectively reduce the incidence of metabolic syndrome and insulin resistance, both thought to be key contributors to PCOS.
"We are grateful for the support and commitment demonstrated by NVN Therapeutics," said Sasha Ottey, executive director of PCOS Challenge, Inc. "NVN Therapeutics' support will significantly help in our mission to make PCOS a public health priority and to help bring answers to the millions of women and families affected by the condition. Despite affecting one-in-ten women, PCOS gets very little attention in the media and most people are unaware of the condition. PCOS is often under-diagnosed and those who have been diagnosed are left wanting for more resources. With the help of visionary companies like NVN Therapeutics, this can change."
About PCOS Challenge
PCOS Challenge, Inc. is a 501(c)(3) nonprofit organization that provides support for women with polycystic ovarian syndrome through television and radio programming, educational workshops and online and offline support networks. For more information about PCOS Challenge, Inc., visit http://www.pcoschallenge.com.
About NVN Therapeutics
NVN Therapeutics develops and manufactures medical foods, which combine the best of science and nature. Established in 2011, the company's inaugural family of products is formulated with the clinically proven Glucorein™ blend of chlorogenic acid and other medical foods. The company is headquartered in Sacramento, California. More information can be found at www.nvnth.com.
NVN Therapeutics Dan McFadden Vice President of Marketing and Public Relations (425) 753-2105